Clinical Trial TitleThe Chronic Grief Management Intervention: An online video group (CGMI-V) study will test an intervention designed to help caregivers after placing a family member in a long-term care facility.
Clinical Trial Protocol Description:
The purpose of this study is to test how an online group-based intervention affects dementia caregivers whose family members live in long term care facilities. The study aims to improve caregivers’:
- Knowledge about late-stage dementia.
- Communication and conflict resolution skills.
- Skills managing their reactions to loss, including chronic grief.
Caregivers will be randomly assigned (like the toss of a coin) to either receive the 8-week group-based Chronic Grief Management Intervention-Video-streamed online (CGMI-V) or to a minimal treatment condition. Caregivers in the CGMI-V condition will participate in an online video group for 8 consecutive weeks in up to 60-minute sessions. Caregivers in the minimal treatment will receive written information about late-stage Alzheimer’s disease or a related dementia (ADRD) only. All caregivers will take part in 3 assessments over the phone at baseline, 8, and 24 weeks.
Length of participation is 24 weeks. Payment for participation is available.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Are 21 years of age or older.
- Are a caregiver to a person with a documented diagnosis of Alzheimer’s Disease or a Related Dementia (ADRD) residing in any type of unit in a long term care facility
- Are able to read and speak English.
- Have basic computer literacy and in-home internet access.
You will be excluded from the study if any of the following criteria apply to you:
- Are a caregiver to a person who does not have a diagnosis of dementia.
- Are currently attending support group for grief management.
This is a partial list of eligibility requirements.
Clinical Trial Investigator
RUSH University Medical Center
1620 W Harrison St
Chicago, IL 60612